India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual property protection for pharmaceuticals. India maintains its intellectual property regime is compliant with international trade rules. This ongoing issue reflects long-standing differences between the two nations. India's stance aims to protect its generics industry and ensure access to affordable healthcare worldwide.